An overview of human proteins and genes involved in SARS-CoV-2 infection

Posted on | Posted on John Murphy | Leave a Comment on An overview of human proteins and genes involved in SARS-CoV-2 infection

Zohreh Jahanafrooz,a,⁎ Zhishan Chen,b Jiandong Bao,c Hongzhi Li,d Loren Lipworth,b and Xingyi Guob,e,⁎Gene. 2022 Jan 15; 808: 145963. Published online 2021 Sep 14. doi: 10.1016/j.gene.2021.145963 PMCID: PMC8437745PMID: 34530086 Graphical abstract A summarized view of recent findings of host proteins interacting with SARS-CoV-2 and genes containing associated variants with COVID-19 susceptibility and severity. The left side of the figure (A) shows host protein interactors (blue wrote) for […]

Disruption of the blood-brain barrier due to long COVID

Posted on | Posted on John Murphy | Leave a Comment on Disruption of the blood-brain barrier due to long COVID

Bhavana Kunkalikar Jan 27 2023 Reviewed by Aimee Molineux, https://doi.org/10.21203/rs.3.rs-2069710/v2 In a recent study posted to the Research Square* preprint server, researchers explored the destruction of the blood-brain barrier (BBB) due to cognitive impairment associated with long coronavirus disease (COVID). Background Studies have demonstrated microvascular injuries observed in the brains of deceased severe acute respiratory syndrome coronavirus 2 […]

Saliva changes in composition associated to COVID-19: a preliminary study

Posted on | Posted on John Murphy | Leave a Comment on Saliva changes in composition associated to COVID-19: a preliminary study

Alberto Muñoz-Prieto, Ivana Rubić, Juan Carlos Gonzalez-Sanchez, Josipa Kuleš, Silvia Martínez-Subiela, José Joaquín Cerón, Enrique Bernal, Alberto Torres-Cantero, María Rosario Vicente-Romero, Vladimir Mrljak & Asta Tvarijonaviciute  Scientific Reports volume 12, Article number: 10879 (2022) Cite this article Abstract The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2), is usually associated with a wide variety of clinical presentations from asymptomatic to severe cases. The use of […]

Alopecia Areata after COVID-19 Vaccines

Posted on | Posted on John Murphy | Leave a Comment on Alopecia Areata after COVID-19 Vaccines

Lucia Genco,* Mariateresa Cantelli, Matteo Noto, Teresa Battista, Angela Patrì, Gabriella Fabbrocini, and Maria Vastarella Skin Appendage Disord. 2023 Mar; 9(2): 141–143. Published online 2023 Jan 19. doi: 10.1159/000528719 PMCID: PMC9892995 PMID: 36926281 Abstract Introduction Alopecia areata (AA) is a common autoimmune disease characterized by non-scarring hair loss. New onsets of AA have been associated with coronavirus disease 2019 (COVID-19). Various skin diseases have already been […]

Structural biology of SARS-CoV-2 and implications for therapeutic development

Posted on | Posted on John Murphy | Leave a Comment on Structural biology of SARS-CoV-2 and implications for therapeutic development

Haitao Yang & Zihe Rao  Nature Reviews Microbiology volume 19, pages685–700 (2021) Cite this article Abstract The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an unprecedented global health crisis. However, therapeutic options for treatment are still very limited. The development of drugs that target vital proteins in the viral life cycle is a feasible approach […]

Headaches and COVID-19 Long-Haulers: What to Know

Posted on | Posted on John Murphy | Leave a Comment on Headaches and COVID-19 Long-Haulers: What to Know

September 16, 2021 / Brain & Spine The Cleveland Clinic Skull-pounding headaches can continue for weeks or even months after you test positive for COVID-19, with around-the-clock pain separated only by periods of agonizing and extreme spikes. It’s one of the most common symptoms being experienced by a group known as COVID-19 long-haulers, or those with lingering issues […]

UK scientists find link between proteins related to blood clots and long Covid

Posted on | Posted on John Murphy | Leave a Comment on UK scientists find link between proteins related to blood clots and long Covid

Biomarker discovery indicates that sufferers from brain fog and fatigue post-virus could be treated with anticoagulants Oksana Pyzik 31 Aug 2023 The Guardian Scientists have identified molecular signatures in the blood that are linked to brain fog, other cognitive problems and fatigue in patients who are diagnosed with long Covid after catching the virus. Raised levels of […]

Serum vitamin D levels can be predictive of psoriasis flares up after COVID-19 vaccination: a retrospective case control study

Posted on | Posted on John Murphy | Leave a Comment on Serum vitamin D levels can be predictive of psoriasis flares up after COVID-19 vaccination: a retrospective case control study

Emmanouil Karampinis1 George Goudouras1 Niki Ntavari1 Dimitrios Petrou Bogdanos2† Angeliki-Victoria Roussaki-Schulze1† Efterpi Zafiriou1*† Front. Med., 25 May 2023 Sec. Dermatology Volume 10 – 2023 | https://doi.org/10.3389/fmed.2023.1203426 Introduction: Many patients with chronic inflammatory dermatosis such as psoriasis usually ask about the safety of COVID-19 vaccination and if it would affect the course of their disease. Indeed, many case reports, case series and clinical […]

Scientists Gain Insight Into COVID’s Heart Impact

Posted on | Posted on John Murphy | Leave a Comment on Scientists Gain Insight Into COVID’s Heart Impact

(02 October 2023 Newsmax Health Day New research shows the COVID-19 virus can directly infect coronary arteries, inflaming fatty plaque inside them, which can increase the risk of heart disease and stroke. This may explain why some people who get COVID-19 have a greater chance of developing heart disease. It also may shed light on […]

New onset and exacerbation of psoriasis after COVID-19 vaccination

Posted on | Posted on John Murphy | Leave a Comment on New onset and exacerbation of psoriasis after COVID-19 vaccination

Nancy Wei, BA,a,∗ Mindy Kresch, BS,b Emily Elbogen, PA-C,c and Mark Lebwohl, MDc JAAD Case Rep. 2022 Jan; 19: 74–77. Published online 2021 Nov 29. doi: 10.1016/j.jdcr.2021.11.016 PMCID: PMC8628636 PMID: 34869811 Introduction The messenger RNA (mRNA)-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) vaccines were granted emergency use authorization during the ongoing COVID-19 pandemic by the United States Food and Drug Administration in December 2020.1 An adenoviral vector […]